FDA 483 - Abbott Laboratories Inc. - May 02, 2023
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
This FDA Form 483 was issued to Abbott Laboratories Inc. in Casa Grande, AZ, following an inspection of their infant formula manufacturing facility. Observations included failures to establish adequate process controls to prevent microbial adulteration, specifically regarding water event management and environmental pathogen response. Additionally, the firm failed to ensure proper cleaning and sanitization of surfaces that contact infant formula, with inadequate documentation of drying times.
ID · 4b7b9943-9d5b-4012-a9b4-136d28518047